Target of rapamycin inhibitors (TOR‐I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
Background Kidney transplantation is the therapy of choice for many patients with end‐stage
kidney disease (ESKD) with an improvement in survival rates and satisfactory short term …
kidney disease (ESKD) with an improvement in survival rates and satisfactory short term …
Mammalian target of rapamycin inhibitors combined with calcineurin inhibitors as initial immunosuppression in renal transplantation: a meta-analysis
N Montero, M Quero, E Melilli, MJ Pérez-Sáez… - …, 2019 - journals.lww.com
Background. The current standard of care immunosuppressive regimen in kidney
transplantation (KT) includes a combination of mycophenolates (MMF/MPA) with a …
transplantation (KT) includes a combination of mycophenolates (MMF/MPA) with a …